Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 918 studies with search of: | "Paraproteinemias" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
|
||||
2 | Terminated |
Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia
|
||||
3 | Completed |
Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
|
||||
4 | Recruiting |
Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
|
||||
5 | Recruiting |
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant
|
||||
6 | Completed |
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
|
||||
7 | Recruiting |
Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance
|
||||
8 | Active, not recruiting |
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
|
||||
9 | Recruiting |
Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
|
||||
10 | Recruiting |
Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
|
||||
11 | Recruiting |
RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy
|
||||
12 | Completed |
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
|
||||
13 | Completed |
Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
|
||||
14 | Active, not recruiting |
Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
|
||||
15 | Completed |
Pyroxamide in Treating Patients With Advanced Cancer
|
||||
16 | Recruiting |
Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
|
||||
17 | Not yet recruiting |
A Novel Vaccine for the Treatment of MUC1-Expressing Tumor Malignancies
|
||||
18 | Active, not recruiting |
Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
|
||||
19 | Active, not recruiting |
A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
|
||||
20 | Completed |
Safety and Anti-Disease Activity of CHR-2797 in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |